Detalhe da pesquisa
1.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 24(12): 1359-1374, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926100
2.
Patients' views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer.
Support Care Cancer
; 31(12): 658, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889343
3.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580883
4.
Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing.
Psychooncology
; 27(4): 1264-1269, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448311
5.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 18(7): 929-945, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600210
6.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339115
7.
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 16(16): 1605-16, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522334
8.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490608
9.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
Lancet Oncol
; 13(1): 43-54, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22169269
10.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991196
11.
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
J Clin Oncol
; 40(22): 2468-2478, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298280
12.
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).
Eur Urol Oncol
; 4(6): 980-992, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489210
13.
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
Lancet
; 373(9676): 1681-92, 2009 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447249
14.
Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer.
Psychooncology
; 19(1): 77-84, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19194996
15.
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
J Clin Oncol
; 38(28): 3261-3272, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663119
16.
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 100(5): 1179-1189, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722660
17.
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.
J Natl Cancer Inst
; 107(10)2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26242893
18.
Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge.
Cancer Imaging
; 13(4): 591-601, 2013 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24433993
19.
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
Radiother Oncol
; 100(1): 93-100, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21752481
20.
Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
BJU Int
; 96(1): 48-53, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15963119